PubRank

Evaluating Demand Creation Strategies for Voluntary Medical Male Circumcision (VMMC) in Kenya (TASCO)

Clinical Trial ID NCT02497989

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02497989

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005 42.71
2 Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007 38.98
3 Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007 37.69
4 Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS 2000 8.94
5 Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med 2011 7.56
6 Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev 2009 4.86
7 Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med 2006 4.34
8 Male circumcision for HIV prevention: from evidence to action? AIDS 2008 4.11
9 Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med 2009 4.05
10 Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis 2007 2.83
11 Acceptability of medical male circumcision among uncircumcised men in Kenya one year after the launch of the national male circumcision program. PLoS One 2011 2.79
12 Methods to assess the costs and health effects of interventions for improving health in developing countries. BMJ 2005 2.75
13 Acceptability of male circumcision for prevention of HIV infection in Malawi. AIDS Behav 2006 2.38
14 Male circumcision for HIV prevention: a prospective study of complications in clinical and traditional settings in Bungoma, Kenya. Bull World Health Organ 2008 2.19
15 The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS 2007 2.19
16 Cost effectiveness of alternative planned places of birth in woman at low risk of complications: evidence from the Birthplace in England national prospective cohort study. BMJ 2012 2.01
17 Voluntary medical male circumcision: a qualitative study exploring the challenges of costing demand creation in eastern and southern Africa. PLoS One 2011 1.60
18 Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8. BMJ 2011 1.48
19 Unrecognized HIV infection among patients attending sexually transmitted disease clinics. Am J Public Health 2002 1.41
20 Male circumcision and HIV prevention: ethical, medical and public health tradeoffs in low-income countries. J Med Ethics 2007 1.34
21 The Prevalence of Undiagnosed HIV Infection in Those Who Decline HIV Screening in an Urban Emergency Department. AIDS Res Treat 2011 1.32
22 Cost effectiveness of community-based and in-patient therapeutic feeding programs to treat severe acute malnutrition in Ethiopia. Cost Eff Resour Alloc 2012 1.21
23 Effectiveness of an opting-out strategy for HIV testing: evaluation of 4 years of standard HIV testing in a STI clinic. Sex Transm Infect 2008 1.11
24 Cost effectiveness of targeted HIV prevention interventions for female sex workers in India. Sex Transm Infect 2011 0.98
25 Individualized cost-effectiveness analysis. PLoS Med 2011 0.92
Next 100